首页> 美国卫生研究院文献>Journal of Cancer >Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin β1-PI3K-AKT Pathway in Lung Cancer
【2h】

Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin β1-PI3K-AKT Pathway in Lung Cancer

机译:中草药温下常服方通过整合素β1-PI3K-AKT途径逆转肺癌细胞粘附介导的耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the treatment of lung cancer, the multidrug resistance to chemotherapeutic drugs is one of the reasons of low rates for cure and treatment failure, the combination of chemotherapeutic drugs and traditional Chinese medicine can increase the sensitivity of chemotherapy and reduce its adverse effects. Our previous study has proved that Chinese herbal medicine (CHM) Wenxia Changfu Formula (WCF for short) effectively enhances chemotherapeutic efficacy in lung cancer treatment and reverses multidrug resistance in lung cancer cells in vitro. The present study aims to investigate the effect and mechanism of WCF in reversing cell adhesion-mediated drug resistance of lung cancer by using A549 three-dimensional cell culture and nude mouse model of the A549 cell line with Integrin β1 overexpression. We show that the combination of WCF with DDP can decrease proliferation of lung cancer cells by inducing cell cycle arrest and apoptosis. Moreover, we find that the combination of WCF with DDP suppresses the expression of certain molecules which regulate cell cycle and apoptosis. Mechanistically, we show that the Integrin β1, FAK, PI3K, and AKT protein expressions are suppressed by DDP and even more responses are observed when DDP and WCF are combined, showing WCF treatment enhances the effect of commonly used anticancer drugs. In line with the above findings, our results confirm that WCF reverses cell adhesion-mediated drug resistance of lung cancer via inactivating Integrin β1/PI3K/AKT and apoptosis induction.
机译:在肺癌的治疗中,对化疗药物的多药耐药性是治愈率和治疗失败率低的原因之一,化疗药物与中药的结合可以提高化疗的敏感性并减少其不良反应。我们以前的研究已经证明,中草药温夏常服配方(简称WCF)可有效增强肺癌治疗的化学治疗功效,并逆转体外肺癌细胞的多药耐药性。本研究旨在通过使用A549三维细胞培养和整合素β1过表达的A549细胞系裸鼠模型研究WCF在逆转细胞粘附介导的肺癌耐药性中的作用和机制。我们表明WCF与DDP的组合可以通过诱导细胞周期停滞和凋亡来减少肺癌细胞的增殖。此外,我们发现WCF与DDP的组合抑制了某些调节细胞周期和细胞凋亡的分子的表达。从机理上讲,我们发现整联蛋白β1,FAK,PI3K和AKT蛋白表达受到DDP的抑制,当DDP和WCF联合使用时,甚至观察到更多的反应,表明WCF治疗增强了常用抗癌药物的作用。与上述发现一致,我们的结果证实WCF通过使整联蛋白β1/ PI3K / AKT失活和诱导凋亡而逆转了细胞粘附介导的肺癌耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号